Startell Bioceuticals Private Limited, a active private limited company, was established on 25 April 2016 in Majiwada, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U52394MH2016PTC280155. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.50 M and a paid-up capital of ₹3.50 M.
It upholds a compliant status. Employing 58 professional, Its leadership includes Nilesh Ramesh Sarode (Director), Bijal Kalpesh Desai (Director). Past directors included Santosh Vidyasagar Dube, Nilesh Ramesh Sarode, Ashish Vidyasagar Dube. It holds ₹6.70 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No.1, Ground Floor, New Hill View Chsl Behind Sachinam Tower., Majiwada, Maharashtra, 400601.
U52394MH2016PTC280155
280155
25 April 2016
₹3.50 M
₹3.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Startell Bioceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nilesh Ramesh Sarode | Director | 05 May 2025 | Current |
| Bijal Kalpesh Desai | Director | 25 Apr 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 May 2025 | Past |
| Pramod Abcsdd | Director | 28 Jul 2016 | Past |
| Pramod Abcsdd | Director | 28 Jul 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Startell Bioceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.93% increase. The company also saw a substantial improvement in profitability, with a 109.16% increase in profit. The company's net worth moved up by a moderate rise of 2.22%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Startell Bioceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹6,700,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Aug 2019 | Others | ₹6.70 M | Open |
Explore comprehensive loan charge details -
Startell Bioceuticals has a workforce of 58 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Startell Bioceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Startell Bioceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Nilesh Ramesh Sarode was appointed as a Director was appointed as a Director on 05 May 2025 & has been associated with this company since 7 months 20 days . was completed.
The activity Startell Bioceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Startell Bioceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
A charge with Others amounted to Rs. 6.70 M with Charge ID 100283813 was registered on 02 Aug 2019. was recorded as a recent event.
Bijal Kalpesh Desai was appointed as a Director was appointed as a Director on 25 Apr 2016 & has been associated with this company since 9 years 7 months . was recorded as a recent event.
Progress on Startell Bioceuticals Private Limited was registered on 25 Apr 2016 with Roc Mumbai & aged 9 years 7 months as per MCA records. was documented.
The CIN of Startell Bioceuticals Private Limited is U52394MH2016PTC280155.
Startell Bioceuticals Private Limited is headquartered at Office No.1, Ground Floor, New Hill View Chsl Behind Sachinam Tower., Majiwada, Maharashtra, 400601.
Startell Bioceuticals Private Limited was incorporated on 25 April 2016.
The current directors of Startell Bioceuticals Private Limited are
The primary industry of Startell Bioceuticals Private Limited is Trade.
Startell Bioceuticals Private Limited is unlisted.
The authorized capital of Startell Bioceuticals Private Limited is ₹3.50 M, and the paid-up capital is ₹3.50 M.
The compliance status of Startell Bioceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX